Zhenzhou Shen Selected Research

Zhenzhou Shen Research Topics

Disease

24	Breast Neoplasms (Breast Cancer) 04/2018 - 06/2007
13	Neoplasms (Cancer) 01/2018 - 05/2002
2	Amenorrhea 04/2018 - 10/2015
2	Hypoxia (Hypoxemia) 01/2018 - 04/2015
2	Neoplasm Metastasis (Metastasis) 01/2011 - 02/2008
1	Residual Neoplasm 01/2017
1	Thrombosis (Thrombus) 03/2016
1	Postoperative Pain 03/2016
1	Postmenopausal Osteoporosis 04/2015
1	Diabetes Mellitus 04/2015
1	Fat Necrosis 04/2014
1	Diarrhea 06/2013
1	Neutropenia 06/2013
1	Disease Progression 12/2010
1	Neoplasm Micrometastasis 05/2002

Drug/Important Bio-Agent (IBA)

8	Estrogen ReceptorsIBA 04/2018 - 06/2007
4	Progesterone Receptors (Progesterone Receptor)IBA 02/2011 - 06/2007
3	Estrogens (Estrogen)FDA Link 01/2018 - 06/2007
3	Hormones (Hormone)IBA 01/2017 - 04/2009
3	ErbB Receptors (EGF Receptor)IBA 07/2014 - 08/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 07/2014 - 12/2010
3	AnthracyclinesIBA 01/2012 - 12/2010
2	Zoledronic Acid (Zometa)FDA Link 01/2018 - 04/2015
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2007
2	Aromatase InhibitorsIBA 01/2017 - 02/2011
2	Letrozole (Femara)FDA LinkGeneric 01/2017 - 04/2015
2	Lapatinib (GW572016)FDA Link 07/2014 - 06/2013
2	taxaneIBA 01/2012 - 10/2011
2	Trastuzumab (Herceptin)FDA Link 03/2011 - 01/2011
2	human ERBB2 proteinIBA 03/2011 - 10/2009
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2018
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2018
1	Follicle Stimulating Hormone (Follitropin)FDA Link 04/2018
1	fluoromisonidazoleIBA 01/2018
1	Fulvestrant (Faslodex)FDA Link 01/2018
1	Cysteine (L-Cysteine)FDA Link 01/2017
1	N(4)-chloroacetylcytosine arabinoside (CACA)IBA 10/2015
1	Pharmaceutical PreparationsIBA 04/2015
1	Epidermal Growth Factor (EGF)IBA 04/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2014
1	TensinsIBA 07/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2014
1	Proteasome InhibitorsIBA 01/2014
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 01/2014
1	Histone Deacetylase InhibitorsIBA 01/2014
1	Bortezomib (Velcade)FDA Link 01/2014
1	suberoyl bis-hydroxamic acidIBA 01/2014
1	Capecitabine (Xeloda)FDA Link 01/2012
1	trioctyl phosphine oxide (TOPO)IBA 10/2011
1	Trefoil FactorsIBA 02/2011
1	Tamoxifen FDA LinkGeneric 02/2011
1	Gemcitabine FDA Link 12/2010
1	Aldehyde Dehydrogenase 1 FamilyIBA 08/2010
1	SulfotransferasesIBA 07/2010
1	ParaffinIBA 10/2009
1	Vinorelbine (Navelbine)FDA LinkGeneric 10/2009
1	Formaldehyde (Formol)FDA Link 10/2009
1	Epirubicin (Ellence)FDA LinkGeneric 10/2009
1	Docetaxel (Taxotere)FDA Link 04/2008
1	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2008
1	Aromatase (CYP19)IBA 06/2007
1	AndrogensIBA 06/2007
1	Coloring Agents (Dyes)IBA 05/2002
1	AntibodiesIBA 05/2002

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 04/2018 - 12/2010
6	Adjuvant Chemotherapy 04/2018 - 01/2011
6	Therapeutics 01/2017 - 12/2010
3	Neoadjuvant Therapy 10/2011 - 10/2009
2	Mammaplasty (Breast Reconstruction) 11/2014 - 04/2014
1	Aftercare (After-Treatment) 01/2017
1	Epidural Anesthesia 03/2016
1	General Anesthesia 03/2016
1	Castration 10/2015
1	Radiotherapy 04/2015
1	Mastectomy (Mammectomy) 11/2014
1	Free Tissue Flaps 04/2014
1	Salvage Therapy 01/2012
1	Combination Drug Therapy (Combination Chemotherapy) 10/2011
1	Extended Radical Mastectomy 02/2008